These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2660772
1. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P. Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772 [No Abstract] [Full Text] [Related]
2. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP. Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478 [Abstract] [Full Text] [Related]
3. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL. Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480 [Abstract] [Full Text] [Related]
4. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD. Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644 [Abstract] [Full Text] [Related]
8. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M. J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490 [Abstract] [Full Text] [Related]
9. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. Charney DS, Woods SW. J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308 [Abstract] [Full Text] [Related]
10. Efficacy of benzodiazepines in panic disorder and agoraphobia. Ballenger JC. J Psychiatr Res; 1990 Nov; 24 Suppl 2():15-25. PubMed ID: 1980694 [Abstract] [Full Text] [Related]
11. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Swinson RP, Pecknold JC, Kuch K. Prog Neuropsychopharmacol Biol Psychiatry; 1987 Nov; 11(2-3):105-13. PubMed ID: 3628823 [Abstract] [Full Text] [Related]
12. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Pecknold JC, Swinson RP, Kuch K, Lewis CP. Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479 [Abstract] [Full Text] [Related]
13. Overview of the Cross-National Collaborative Panic Study. Klerman GL. Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477 [Abstract] [Full Text] [Related]
14. Surreptitious drug use by patients in a panic disorder study. Clark DB, Taylor CB, Roth WT, Hayward C, Ehlers A, Margraf J, Agras WS. Am J Psychiatry; 1990 Apr; 147(4):507-9. PubMed ID: 1969248 [Abstract] [Full Text] [Related]
17. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA. J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639 [Abstract] [Full Text] [Related]
18. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS. J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912 [Abstract] [Full Text] [Related]
19. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia. Klerman GL. J Psychiatr Res; 1990 Apr; 24 Suppl 2():27-41. PubMed ID: 1980697 [Abstract] [Full Text] [Related]
20. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Apr; 241(1):22-30. PubMed ID: 1832302 [Abstract] [Full Text] [Related] Page: [Next] [New Search]